NCT02887222View on ClinicalTrials.gov

Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor-3

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Labor Pain
Interventions
DRUG

Bupivacaine

0.0625% Bupivacaine plus fentanyl 2mcg/ml

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT02887222 - Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor-3 | Biotech Hunter | Biotech Hunter